Infliximab

Details

Files

Generic Name:

Infliximab

Project Status:

Complete

Therapeutic Area:

Ankylosing spondylitis; arthritis, psoriatic; arthritis, rheumatoid; plaque psoriasis

Manufacturer:

Hospira Healthcare Corporation

Call for patient/clinician input open:

July 15, 2014

Brand Name:

Inflectra

Project Line:

Reimbursement Review

Project Number:

SE0384-000

Call for patient/clinician input closed:

September 4, 2014

Biosimilar:

Yes

Submission Type:

Initial

Indications:

Ankylosing spondylitis, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis

Recommendation Type:

List with criteria/condition

Final Recommendation:

December 19, 2014

Last Updated : June 17, 2014